Product Variations
Product # | Price | Quantity | |
---|---|---|---|
VD-OEIA-00092-0010-10mg | $40 | ||
VD-OEIA-00092-0050-50mg | $150 |
$40.00 – $150.00
Brown solid
52238-35-4
VD-OEIA-00092
C17H14N2O·HCL
298.77
≥95%
PBS or H2O
-20°C. Protect from light. Hygroscopic.
5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-ol hydrochloride
10mg, 50mg
Product # | Price | Quantity | |
---|---|---|---|
VD-OEIA-00092-0010-10mg | $40 | ||
VD-OEIA-00092-0050-50mg | $150 |
A cell-permeable antitumor alkaloid that acts as a potent inhibitor of topoisomerase II (IC50 = 3.3 µM).Restores functional wild-type p53 activity via inhibition of mutant p53 protein phosphorylation. Suppresses Cdk2 activity in a concentration-dependent manner. Also reported to inhibit telomerase activity in cultured pancreatic cells, possibly through inhibition of protein kinases. Binds to the aryl hydrocarbon receptor (AhR) in rat lung cytosol and inhibits aryl hydrocarbon hydroxylase (AHH) activity in rat hepatic microsomes.
1.Mizumoto, K., et al. 2000. Cancer Lett. 149, 85.
2.Perry, P.J., et al. 1999. Anticancer Drug Des. 14, 373.
3.Sugikawa, E., et al. 1999. Anticancer Res. 19, 3099.
4.Sato, N., et al. 1998. FEBS Lett. 441, 318.
5.Ohashi, M., et al. 1995. Jpn. J. Cancer Res. 86, 819.
6.Renault, G., et al. 1987. Toxicol. Appl. Pharmacol. 89, 281.
Reviews
There are no reviews yet.